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Abstract
Background: Estrogens from peripheral sources as well as central aromatization are neuroprotective in the
vertebrate brain. Under normal conditions, aromatase is only expressed in neurons, however following anoxic/
ischemic or mechanical brain injury; aromatase is also found in astroglia. This increased glial aromatization and the
consequent estrogen synthesis is neuroprotective and may promote neuronal survival and repair. While the effects
of estradiol on neuroprotection are well studied, what induces glial aromatase expression remains unknown.
Methods: Adult male zebra finches (Taeniopygia guttata) were given a penetrating injury to the entopallium. At
several timepoints later, expression of aromatase, IL-1b-like, and IL-6-like were examined using
immunohisotchemistry. A second set of zebra birds were exposed to phytohemagglutinin (PHA), an inflammatory
agent, directly on the dorsal surface of the telencephalon without creating a penetrating injury. Expression of
aromatase, IL-1b-like, and IL-6-like were examined using both quantitative real-time polymerase chain reaction to
examine mRNA expression and immunohistochemistry to determine cellular expression. Statistical significance was
determined using t-test or one-way analysis of variance followed by the Tukey Kramers post hoc test.
Results: Following injury in the zebra finch brain, cytokine expression occurs prior to aromatase expression. This
temporal pattern suggests that cytokines may induce aromatase expression in the damaged zebra finch brain.
Furthermore, evoking a neuroinflammatory response characterized by an increase in cytokine expression in the
uninjured brain is sufficient to induce glial aromatase expression.
Conclusions: These studies are among the first to examine a neuroinflammatory response in the songbird brain
following mechanical brain injury and to describe a novel neuroimmune signal to initiate aromatase expression in
glia.
Keywords: Aromatase, Cytokine, Estrogen, Neuroinflammation, Glia
Background
Damage to the homeotherm brain increases aromatase
(estrogen synthase) in reactive astroglia [1-3]. Although
constitutive aromatase is abundant and neuronal in the
undamaged songbird brain, glial aromatase expression is
rapidly upregulated following brain damage [1,4-8].
Increased transcription and translation of glial aroma-
tase occurs following damage to the neuropil in song-
birds and to a lesser extent in mammals [2,8-10]. In
songbirds, this upregulation appears more rapid and
robust, since the secondary wave of degeneration char-
acteristic of the mammalian (including human) brain
following TBI is only revealed in songbirds following
inhibition of upregulated glial aromatase [3,11]. Indeed,
estrogen derived from glial aromatase may act by
decreasing reactive gliosis that inhibits neurodegenera-
tion [11]. Further, following injury, estrogens serve to
limit further damage [3,9,10,12,13] by decreasing neuro-
degenerative properties and promoting neuroprotective
pathways [7,14,15]. While much attention has been paid
to the physiological mechanisms whereby estrogen miti-
gates damage and accelerates repair, virtually nothing is
known about what is responsible for the induction of
aromatase in astrocytes.
Among the many changes that accompany traumatic
brain injury (TBI), neuroinflammation due to disruption
of the blood brain barrier may provide a plausible signal
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[16-19]. TBI is characterized by both the physical
damage and a secondary neuroinflammatory response
characterized by increased cytokine and chemokine
expression [19-22]. In very general terms, these events
may be separated into two distinct, but interrelated
phases. In the initial phase the mechanical injury creates
a physical trauma to the brain that results in tissue
damage and cell death [19,21,22]. The secondary phase
of TBI is due to the disruption of the blood brain bar-
rier (BBB) with a subsequent immune and inflammatory
response [19,21,22]. These effects can occur within min-
utes of the trauma and last for weeks to even months
later [22]. The neuroinflammatory response (character-
ized by increased cytokine expression) following injury
can exert both neurotoxic (inflammation, brain swelling)
and neuroprotective (promoting phagocytosis and
repair) actions [18,23].
Cytokines (Interleukins, Tumor Necrosis factors,
Transforming Growth Factors) like aromatase are also
upregulated following injury or damage to the brain.
Their presence following injury has implicated them as
mediators and inhibitors of neurodegeneration
[17,19,23-26]. Cytokine production is not only due to
infiltrating immune cells but also from reactive astro-
cytes. Moreover, microinjections of cytokines into a rat
stab wound significantly increase astrogliosis and cyto-
kines have been implicated in regulating homeostasis in
tissues and promoting repair following disease [19].
Furthermore cytokines regulate aromatase gene expres-
sion via alternate promoters in normal and malignant
breast tissue [27-30] and may provide a plausible signal
for the induction of glial aromatase. While IL-1 has
some ability to increase aromatase activity, the most
potent cytokine stimulator of aromatase is IL-6, a pro-
inflammatory cytokine that is also upregulated following
T B I[ 2 1 , 2 9 - 3 1 ] .T h e s ed a t as u g g e s tau n i q u ea n de n d o -
genous protective mechanism that reduces neurodegen-
eration and may actively inhibit the deleterious effects
of prolonged cytokine action following brain damage.
Here we test the hypothesis that induction of a neu-
roinflammatory response independent of TBI is capable
of inducing aromatase transcription/translation in zebra
finch astrocytes. First, we tested whether neuroinflam-
matory cytokine expression (IL-1 & IL-6) precedes glial
aromatase expression following brain injury. Next, we
tested if an inflammatory response, independent of a
penetrating injury, induces astrocytic glial aromatase.
Methods
Birds
Adult male zebra finches (> 90 days post-hatching) were
obtained from a breeder (Magnolia Bird Farms; Ana-
heim, CA) and housed in the animal facility at Lehigh
University. The Lehigh University Institutional Use and
Animal Care Committee (IACUC) approved of all ani-
mal procedures.
Preliminary Studies. Verification of antigenic IL-1b,
IL-6, and aromatase in zebra finches via Western
Blotting.
The antibody used to detect aromatase has been
extensively characterized [32,33]. To determine if anti-
bodies against IL-1b and IL-6did indeed detect these
antigens in zebra finch, we conducted Western blot
studies.
Birds were collected and decapitated after an overdose
of Isoflurane. The telencephalons were rapidly dissected
quickly frozen in a dry ice methanol bath and placed at
-80°C until use. Brain tissue was homogenized in Hepes
buffer [10 mM Hepes, 10 mM KCl, 0.1 mM EDTA, and
200 μl of 10% IGEPAL/5 ml of buffer A, 1 μl of Protease
inhibitor (Sigma-Aldrich, St. Louis, MO)] and centri-
fuged at 4°C at top speed (15,000-16,000 × g) for 30
min and placed on ice. Supernatant was immediately
removed and placed in -20°C until use. 20 μlo fp r o t e i n
from each sample was run on 4-12% Tris-HCl gels (Bio-
Rad, Hercules, CA). Protein was transferred to a PVDF
membrane (Bio-Rad, Hercules, CA). Membranes were
blocked in 5% non-dairy milk for 3 hours and incubated
overnight at 4°C in primary antibody at 1:1000. Goat
anti-rabbit secondary (Cell Signaling Technology Inc,
Danvers, MA) was applied at 1:3,000 and incubated at
room temperature for 30 min. After a series of washes
in Tris-buffered saline the reaction was visualized with
an ECL Western Blotting Detection kit (Pierce, Rock-
ford, IL) on Hyperfilm ECL (Amersham Biosciences, Pis-
cataway, NJ).
Experiment 1: Temporal Expression of IL-1b-like, IL-6-like,
and Aromatase protein following injury
Injury
Subjects were anesthetized (0.03-0.05 ml/15 g of Nem-
butal (pentobarbital sodium salt from Sigma-Aldrich, St.
Louis, MO, 25 mg/mL in a 20% propylene glycol and
5% ethanol solution) and positioned in a stereotaxic
apparatus with the head angled at 45°. A bilateral cra-
niotomy was created at 2-mm anterior to the pineal
gland and 3-mm lateral to the midline. Injuries were tar-
geted toward the entopallial nucleus 3-mm ventral to
the brain surface [34] because it lacks constitutively
expressed neuronal aromatase [5,7,32,35]. A 22 s Hamil-
ton syringe (Hamilton Company, Reno, NV) was posi-
tioned at the surface of the brain and lowered to the
target where it remained for 60 secs.
Immunohistochemistry (IHC)
Whole brain sections from adult birds were removed
from skull and fixed in 5% acrolein at either 2,4,8, 12,
24, or 72 hrs following penetrating injury. Tissue was
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ing standard immunohistochemistry protocols, free-
floating sections were washed 6 × 10 min in 0.1 MPB,
then tissue was treated with 10% sodium borohydride in
0.1 M PB. Tissue was then placed in 10% normal goat
serum and incubated with primary antibody in 0.1 M
PB with 0.3% Triton-X (Sigma- Aldrich, St. Louis, MO)
for 48 h at 4C. Anti-zebra finch aromatase C-terminal
(AZAC) was used at a concentration of 1:20,000, while
antibodies for IL-1b-like and IL-6-like proteins were
used at a concentration of 1:75,000. Tissue was then
w a s h e d1 0×6m i ni n0 . 1MP Bw i t h0 . 1 %T r i t o n - X
(PBT) and placed in biotinylated rabbit secondary anti-
body for 60 min (Jackson ImmunoResearch Labora-
tories, Inc., West Grove, PA), washed again 3 × 10 min
in 0.1 M PBT and then placed in A/B solution (VectaS-
tain, Burlingham, CA) for 60 min. After incubation and
a series of washes in 0.1 M PBT and 0.175 M sodium
acetate sections were then placed in a chromagen solu-
tion containing diaminobenzidine tetrahydrochloride
(Sigma-Aldrich, St. Louis, MO), hydrogen peroxide, and
Nickel sulfate (Sigma-Aldrich, St. Louis, MO) to visua-
lize the reaction. Sections were mounted on slides and
then coverslipped after serial dilutions in alcohol and
zylene (Fisher Scientific, Pittsburgh, PA). IHC were pre-
formed simultaneously on brains to control for any
between-run differences in staining procedures. Repre-
sentative micrographs were obtained from non-overlap-
ping sections surrounding the injury tract and rendered
using NIH Image J. An experimenter blind to the source
of the photomicrographs counted the total number of
labeled cells within the injured entopallium per 0.3
mm
2. Data from images within individual injuries and
subjects were averaged, and group means representing
the number of labeled cells were computed across treat-
ment [35].
Co-Expression of Glial/Microglia Markers and Aromatase/IL-
1b-like and IL-6-like
To determine the nature of cells expressing either aro-
matase or IL-1b-like and IL-6-like we used double-label
immunocytochemistry. Vimentin (Developmental studies
Hybridoma Bank, Iowa City, IA) has been previously
used as a glial marker in the avian brain [36]. Sections
were washed 6 × 10 min in 0.1 MPB, then tissue was
treated with 10% sodium borohydride in 0.1 M PB. Tis-
sue was then placed in 10% normal goat serum and
incubated in a primary antibody cocktail containing
1:2500 AZAC [32] and 1:750 anti-vimentin in 0.3% PBT
(48 h, 4C). Tissue was then washed 10 × 6 min in 0.1
M PB with 0.1% Triton-X (PBT) to remove excess pri-
mary and then incubated in a secondary antibody cock-
tail containing 1:50 mouse-adsorbed, goat anti-rabbit
cyanine-5 (CY-5) and 1:50 rabbit-adsorbed, goat anti-
mouse cyanine-2 (CY-2; Jackson Immunochemicals,
West Grove, PA) in 0.3% PBT for 2 h at room tempera-
ture under foil. Sections were then washed in 0.1% PBT
for a total of 2 h, mounted, dehydrated, and cover-
slipped. For studies examining the co-expression micro-
glial markers and cytokines, sections were washed 6 ×
10 min in 0.1 MPB, then tissue was treated with 10%
sodium borohydride in 0.1 M PB. Tissue was then
placed in 10% normal goat serum and incubated in a
primary antibody at 1:50,000 for 48 h at 4C. Tissue was
then washed 10 × 6 min in 0.1 M PB with .1% Triton-X
(PBT) to remove excess primary and then incubated in
a secondary antibody cocktail containing 1:50 mouse-
a d s o r b e d ,g o a ta n t i - r a b b i tc y a n i n e - 5( C Y - 5 )a n d1 : 1 0 0 0
isolectin GS-IB4 from Griffonia simplicifolia,A l e x a
Fluor
® 488 conjugate (Invitrogen, Carlsbad, Ca) for 2 h
at room temperature under foil. Sections were then
washed in 0.1% PBT for a total of 1 h, mounted, dehy-
drated, and coverslipped. Isolectin B4 stains microglial
cells in the adult CNS and also has a lower affinity to
vascular endothelial cells [37,38].
Confocal Microscopy
Sections double-stained with antibodies against vimen-
tin/aromatase or isolectin(IB4)/IL-1 or IL-6 were
inspected under a scanning confocal microscope. Sec-
tions were observed using a 10X or 25X/1.4 NA plan
apo objective on an inverted microscope (Zeiss Axiovert
200 M) equipped with a Zeiss LSM510 META scan
head. Argon ion, 543 HeNe, and 633 HeNe lasers were
used to generate the 488, 543, and 633 lines used for
excitation, and pinholes were typically set to 1-1.5 airy
units.
Experiment 2: Phytohemagglutin (PHA) induced
neuroinflammation on glial aromatase expression
PHA induced neuroinflammation
Subjects were anesthetized (0.03-0.05 ml/15 g of Nem-
butal (pentobarbital sodium salt from Sigma-Aldrich, St.
Louis, MO, 25 mg/mL in a 20% propylene glycol and
5% ethanol solution) and positioned in a stereotaxic
apparatus with the head angled at 45°. A bilateral cra-
niotomy was created at 2-mm anterior to the pineal
gland and 3-mm lateral to the midline. Either phytohe-
magglutin [PHA, stimulates T lymphocytes to release
cytokines, 39] or saline was dripped over the open sur-
face of the brain, with special care taken not to damage
the brain or the dura mater.
Immunohistochemistry (IHC)
The entire brain was removed from the skull and fixed
in 5% acrolein either 6 h or 24 h following neuroinflam-
mation. Tissue was cut on a cryostat at 40 μma f t e r
being gel embedded and stored in cryoprotectant at
-20C until use. The same protocol stated above was
used for analysis of cytokines and aromatase. For
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least four images were taken per animal and an uncali-
brated optical density was calculated using NIH Image J
and averaged across the images and animals. To deter-
mine the extent of programmed cell death induced by
the penetrating injury vs. PHA induced neuroinflamma-
tion, sections were exposed to terminal deoxynucleotidyl
transferse UTP nick end labeling (TUNEL), which labels
the ends of degenerating DNA, thereby permitting
visualization of apoptotic nuclei. The sections were pro-
cessed as previously published [7] using the TUNEL
Apoptosis Detection Kit (Upstate Biotechnology, Wal-
tham, MA).
qPCR
Birds (n = 8) were decapitated 24 hours following treat-
ment and each telencephalic lobe rapidly dissected out
into 1 mL of Trizol reagent (Invitrogen, Carlsbad, CA,
USA) and completely homogenized. Total RNA was iso-
lated from the samples using the methods suggested by
the manufacturer. Samples were analyzed on a ND-1000
spectrophotometer (NanoDrop, Wilmington, DE, USA),
and only those samples that had a 260/280 ratio that
exceeds 1.85 were used. For every qPCR experiment, 3 g
of total RNA was reverse transcribed with an oligo(dT)
20 using the Superscript III first strand synthesis kit for
reverse transcription polymerase chain reaction (RT-
PCR; Invitrogen, Carlsbad, CA, USA). For qPCR, 1 μL
(or 5% of the total first strand synthesis reaction) of the
resulting cDNA was amplified with Power SYBR Green
PCR master mix (Applied Biosystems, University Park,
IL, USA) in 25 μL of total reaction volume. Assays were
done in 96-well optical plates and each sample was
amplified in triplicate. In every run, wells without the
RT product were included in order to detect any exter-
nal contamination. Amplicons were generated against
exons of the zebra finch aromatase transcript, as well as
the housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase [GAPDH; see 40]. Primers were designed
using zebra finch aromatase and GAPDH-specific
sequences found in the GenBank database (GenBank
accession numbers AF170274, AF170273, S75898 and
AF255390).
Statistics
The mean cell counts for IL-1b-like, IL-6-like, and aro-
matase were analyzed separately using a one-way analy-
sis of variance with treatment as the variable. These test
were followed by Tukey-Kramer HSD post hoc analysis
for pairwise comparisons when significant main effects
were determined. mRNA expression data were analyzed
using a t-test, with treatment as the main variable. Den-
sitometry data were analyzed using an ANOVA with
treatment and time following surgery as the main vari-
ables. Post hoc analysis was used to determine indivi-
dual differences. JMP statistical analysis software (SAS,
Cary, NC) was used to generate analysis. For all test
results a predetermined level of a = 0.05 was used.
Results
Specificity of antibodies
To the best of our knowledge, immunoreactive cyto-
kines have not been described in the passerine brain.
Consequently, IL-1b-like and IL-6-like proteins were
detected using chicken (Gallus gallus) specific antibo-
dies (Pierce, Thermo Scientific; Rockford, IL). The pre-
dicted zebra finch IL-1b-like and IL-6-like nucleotide
and protein sequences had high sequence identity
(> 80%) with chicken nucleotide and protein identities.
T h e s ed a t ai n d i c a t eah i g hh o m o l o g yb e t w e e nt h et w o
avian species and suggest a high likelihood of specific
antibody binding. Also to test for the specificity of
these antibodies, western blot analysis was run. Wes-
tern blot analysis revealed a single band of an apparent
size of 17 kD detected for IL-1b-like and of 21 kD for
IL-6-like (Figure 1A-B).
Temporal Expression of IL-1b-like, IL-6-like, and
Aromatase following injury
IL-1b-like immunoreactivity
IL-1b-like immunoreactivity (IL-1b-like-ir) was detect-
able as early as 2 hrs post-injury, but was dramatically
higher at 4 hrs where it reached maximum. IL-1b-like-ir
declined following 4 hrs following injury, however began
to increase again 24 hrs post injury and was significantly
different across the times examined (Figure 2A; F5,15=
6.4938, p = 0.0061). Anatomical structural analysis and
coexpression studies suggest that these cells are micro-
glia due to their differences in shape and size when
compared to both neuronal and astrocytic aromatase
(Figure 1C-F).
IL-6-like Immunoreactivity
IL-6-like immunoreactivity (IL-6-like-ir) was also detect-
able at 2 hrs and was maximal at 4 hrs post-injury, and
followed a similar pattern of expression as IL-1b-like-ir.
Notably, IL-6-like-ir differed from IL-1b-like-ir 24 hrs fol-
lowing injury where IL-6-like-ir was back to levels
observed at 8 hrs following injury, unlike IL-1b-like-ir
which showed a slower increase in expression. Similar to
IL-1b-like-ir, IL-6-like-ir was significantly different follow-
ing injury (Figure 2B; F5,15= 16.7474, p = 0.0001). Anato-
mical structural analysis and coexpression studies suggest
that these cells are microglia as well (Figure 1G-J).
Aromatase Immunoreactivity
Maximal expression of aromatase occurred at 24 hrs fol-
lowing a rise of expression that started 8 hrs following
injury and dropped at 72 hrs following injury. Despite
this drop in expression between 24 and 72 hrs, expres-
sion at 72 hrs was still higher than 0-12 hrs post injury
where aromatase immunoreactivity is lowest, and was
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(Figure 2C; F5,15= 355.5745, p < 0.001). Injury induced
glial aromatase immunoreactive cells have been pre-
viously described as astrocytes and not microglia [1,41].
PHA induces a neuroinflammatory response in the
zebra finch brain independent of a penetrating injury.
To confirm that PHA treatment was truly related to
neuroinflammation two markers of neuroinflammation
were examined (IL-1b-like and IL-6-like; Figure 3). 6 h
following surgery, both IL-1b-like and IL-6-like were
upregulated over controls. Statistical analysis was used
to confirm this effect and found that both IL-1b-like
(Figure 3A) and IL-6-like (Figure 3B) were significantly
different than controls (F3,15 = 110.73, p < 0.0001; F3,15
= 28.4698, p < 0.0001), respectively. This effect
appears to be short term as cytokines appear to return
to baseline 24 hours following treatment anatomical
and structural analysis suggests that these immunor-
eactive cells are microglia as opposed to astrocytes
(Figure 3C).
Aromatase expression following neuroinflammation
Aromatase mRNA expression was greater on the side of
the brain exposed to PHA than exposed to saline
(Figure 4A). Comparative Ct measurements give a rela-
tive expression difference between samples, where a
lower number means greater expression and were used
to determine the mRNA expression following treatment.
24 h after inducing a proinflammatory response, the
PHA groups had significantly lower delta Cts (increased
mRNA expression) than saline controls (t(13) = 2.868, p
< 0.0100; Figure 4A). Data was converted to fold-change
and showed that there was significant difference
between the control and PHA treated areas, with PHA
treatment significantly increasing aromatase expression
over control (t(13) = 4.857, p = 0.0003; Figure 4B).
Aromatase immunoreactivity following PHA treatment
PHA induced aromatase expression in glia without a
penetrating injury. Exposing the brain to PHA, but not
saline increased expression of aromatase ir-cells 24 h
following surgery (Figure 5). Further analysis of
Figure 1 Interleukin antibody specificity and cellular characterization. Western blot analysis of IL-1b-like (A) and IL-6-like (B). Representative
high power magnification of IL-1b-like (C) and IL-6-like (G) immunoreactive cells in the zebra finch brain. IL-1b-like (D-F) and IL-6-like (H-J) cells
around injury coexpress microglial proteins (yellow, (F, J). Panels (D-E) and (H-I) reveal the identical field of cells viewed through the green
(microglia) and red (IL-1b-like and IL-6-like) channels alone.
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aromatase is localized to the side of the brain that
received PHA treatment only (Figure 5A) and that neu-
ronal aromatase is present on both sides of the brain
(Figure 5D-E). Also, the size and shape of aromatase
ir-cells suggest that the cells present are in fact glia
(Figure 5B-C) and coexpression with vimentin con-
firmed that these cells are indeed astrocytes (Figure 6).
Cell death Assay
PHA induced neuroinflammation does not cause cell
death. Following a penetrating injury increased cell
death and increased glial aromatase is observed. In the
PHA groups, we observed increased aromatase expres-
sion, but no corresponding increased cell death markers
(Figure 7).
Discussion
In this study, we examined the temporal pattern of IL-
1b-like and IL-6-like and aromatase following injury to
the zebra finch brain and whether neuroinflammation
affects glial aromatase transcription and translation. Fol-
lowing injury both IL-1b-like and IL-6-like protein were
localized around the injury site, with maximal expres-
sion occurring at 4 hrs post injury. In contrast aroma-
tase expression increaseda b o u t2 4h r sp o s ti n j u r y .
Thus, cytokine expression precedes aromatase expres-
sion and thus could serve as the biological inducer of
glial aromatase expression. To further examine the role
that cytokines may serve in inducing neuroendocrine
factors such as aromatase we induced a neuroinflamma-
tory state characterized by increased expression of two
cytokines (IL-1b-like and IL-6-like) and was able to
increase glial aromatase transcription and translation.
Importantly, this neuroinflammatory state was not
accompanied by cell death and occurred prior to the
increase in glial aromatase transcription and translation.
These data indicate that cytokines may serve to induce
neuroendocrine factors such as aromatase, which in
turn, is neuroprotective.
Prior to this study, a mechanism to explain the induc-
tion of glial aromatization in the avian and mammalian
brain following injury or damage was yet forthcoming.
Two major physiological events that accompany brain
injury are; (a) disruption of the blood brain barrier with
a consequent inflammatory response that helps and hin-
ders repair and (b) cell death during and following the
primary injury [21,22]. Subsequently, both could be
plausible signals underlying glial aromatization.
Role of neuroinflammation on glial aromatase expression
Expression of both IL-1 and IL-6 preceded aromatase
expression and without any noticeable cell death we were
able to induce glial aromatase expression with neuroin-
flammation alone. Studies in non-neuronal tissue (breast
a n do v a r i a n )s h o wt h a tI L - 1 b and IL-6 upregulate aroma-
tase expression [27,30,42-45]. The present data extend
these findings into the brain in vivo and suggest a novel
role for cytokines on the initiation of glial aromatase
expression. Interestingly, estrogens (the expected result of
Figure 2 Temporal expression of IL-1b-like immunoreactive
cells (A), IL-6-like (B), and Aromatase (C) following mechanical
injury in the zebra finch brain. Data are represented as mean ±
SEM. Data not connected by the same letter are significantly
different (p < .05).
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neuroinflammation by targeting expression of proinflam-
matory cytokines from astrocytes [46,47]. Studies in the
songbird have elucidated that glia-derived estrogen may
act by decreasing reactive gliosis that inhibits neurode-
generation [11]. Both cytokines studied did decline, how-
ever this drop in expression occurred prior to a
significant increase in aromatase expression. We have
previously shown that aromatase expression is still upre-
gulated 6 weeks following injury [11], and the lack in a
decline in cytokine expression may be due to a temporal
delay in the conversion of steroidogenic precursors to
estrogen that may extend beyond the time-points studied.
Also, aromatase via estrogens may mitigate a greater rise
in cytokine response at later time-points (> 72 hrs).
Selective estrogen receptor modulators (SERM) have
been studied for their use and have proven to be just as
useful as estradiol alone in decreasing cytokine expression
and neuroinflammation [46,48,49]. Interestingly, we
detected a decrease in cytokine production following
PHA exposure, this decrease in inflammatory response
may be due to transient nature of the inflammatory
response itself or due to the predicted increase in estro-
gen production. Future research is needed to elucidate
which mechanism is responsible for the decline in cyto-
kine expression following PHA treatment. However, these
data suggest that neuroprotection is mediated by the clas-
sic activation of both ER-a and/or ER-b that subse-
quently increase gene expression of factors regulating
neuroprotective mechanisms [46,50,51].
Role of cell death on glial aromatase expression
As stated previously, cell death is a consequence of pri-
mary injury to the brain, thus cell death both pyknotic
and apoptotic could be a mechanism underlying the
induction of glial aromatase. Therefore, we compared
apoptosis levels in the PHA-exposed brain to that of a
mechanically injured brain and failed to detect cell
death or degeneration due to PHA alone. Since cell
death was readily detectable due to mechanical injury
the data suggest that neither PHA induced neuroinflam-
mation nor the surgery to expose the brain to PHA
result in cell death and thus cell death is not necessary
to increase glial aromatase expression. However it is
important to point out that estrogen provision is a
potent mitigator of apoptotic secondary degeneration
and both apoptosis and neural injury are markedly
decreased by glial aromatase [7,11,15,35,52,53].
Cytokines as neuroprotective
Presumably, PHA caused the release of cytokines from
microglial following T-lymphocyte stimulation [39]
Figure 3 Bar graph depicting the mean uncalibrated optical density (OD) for IL-1b-like (A) and IL-6-like (B) immunoreactive cells at 6
h and 24 h following treatment with PHA. (C) Representative sections depicting the localization of IL-1-like (top) and IL-6-like -ir cells
(bottom) following PHA treatment. * denotes a significant difference between treatment and saline.
Figure 4 Bar graph showing the mean ± SEM in ΔCt values
(normalized against GAPDH, (A)) and fold change (B) between
saline and PHA treated telencephalons for aromatase. Fold
change in expression was calculated using the double delta Ct
method assuming 100% efficiency. * denotes a significant difference
between treatment and saline.
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kines then creates and inflammatory response and notably,
can exacerbate neurodegeneration [17,19,21,54]. However
recent evidence suggests that expression of cytokines can
also be neuroprotective via expression of factors related to
neurogenesis and repair [23,55,56]. Interestingly, a second
rise in cytokine expression occurred in the injury tissue
and may signal the shift from neurodegeneration to repair
in damaged tissue. IL-6 in particular, is known to shift
from a pro-inflammatory mediator to an anti-inflamma-
tory/neuroprotective role following injury [57-59]. This
shift also occurs in both the localization and function of
IL-1b following injury. Initially of IL-1b is localized within
microglia and serves as a pro-inflammatory cytokine, how-
ever later the expression of IL-1b can shift to astrocytes
and serves to increase the production of inflammatory
Figure 5 Representative sections from male zebra finches for aromatase immunoreactivity (Arom-ir) following exposure to PHA and
saline. (A) Low power magnification of Arom-ir following exposure to PHA (left) and saline (right). (B) Higher power magnification of Arom-ir
cells after exposure to PHA. (C) High power magnification exhibiting the typical cellular morphology and structure of Arom-ir cells following
exposure to PHA. (D) Control section showing that normal Arom-ir is not affected by treatment with PHA (left) or saline (right). (E) High power
magnification showing neuronal expression of aromatase.
Figure 6 Panels (A) and (B) reveal the identical field of cells viewed through the red (aromatase (B)) and green (vimentin (C)) channels
alone. Aromatase cells coexpress glial proteins (yellow, C).
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Page 8 of 11mediators [60-63]. Further research is needed to fully test
this hypothesis, however the rise in aromatase expression
may serve to also shift the expression and localization of
these cytokines into a neuroprotective state and thus pro-
long the expression of glial aromatase.
Neuroimmune-Neuroendocrine Interactions as a novel
mechanism of neuroprotection
We have presented an interaction between cytokines
and glial aromatase and thereby neurodegeneration, and
neuroprotection. These data along with our own, pro-
vide a conceptual framework for the mechanisms under-
lying cytokines, aromatase, and estrogens in the brain
following injury (Figure 8). These data support the
emerging theory that neuroinflammation and cytokine
expression following injury are not always detrimental
to the organism, but may be necessary for the neuropro-
tective actions of aromatase and estrogen [23,55,56].
While cytokines appear to increase neuroinflammation,
which can be very damaging to the brain, they also acti-
vate genes to protect the brain against further damage.
These protective genes may also have a reciprocal action
that decrease the cytokine response quite possibly limit-
ing the extent of the neuroinflammation as well. Further
research is needed to fully understand this complex
interaction between neurotoxicity and neuroprotection.
Conclusions
We show that the cytokine response occurs prior to the
glial aromatase response, and strongly suggest that cyto-
kine expression is necessary for the shift in purely neu-
ronal aromatase expression to a population of both
neuronal and glial aromatase. Our findings suggest that
following TBI, increased inflammation caused by
increased cytokine expressione v o k e san e u r o p r o t e c t i v e
pathway involving aromatase. This increased aromatase
expression may represent an interesting candidate to
counteract neuroinflammation under times of stress.
Studies using the songbird as a model have revealed a
unique and endogenous protective mechanism that
reduces neurodegeneration and may actively inhibit
the deleterious effects of prolonged cytokine action fol-
lowing brain damage. These data are key to our under-
standing of the mechanisms regulating aromatase-
mediated neuroprotection.
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